H1 2024 conference call to be held on August 22, at 8:30 a.m. Eastern Time
HONG KONG, Aug. 15, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, including Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care, and more, today announced that it expects to release its financial results for H1 2024, ended June 30, on Wednesday, August 21, 2024.
Sisram's management team will host a conference call to discuss the financial results on Thursday, August 22, 2024, at 8:30 a.m. Eastern Time.
Speakers will include Mr. Liu Yi, Sisram's Chairman, Mr. Lior Dayan, Sisram's Chief Executive Officer, Mr. Doron Yannai, Alma's CFO, and Ms. Qianli Fang, Sisram's VP of IR and Secretary of the Board. Following the prepared remarks, management will be available for a question-and-answer session.
The conference call can be accessed using the following link: https://s.comein.cn/AHyWW
Alternatively, participants can dial-in with the below numbers, using the passcode: 552254
United States: +1-646-860 9590
China Mainland: +86-400 188 8933
Hong Kong S.A.R: +852-5700 6913
Taiwan Region: +886-(0)2-7741 4091
Singapore: +65-3158 6120
International: +86-010-89632651
The conference call will begin at:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time
A replay will also be available on Sisram Medical's IR Events & Presentations page.
About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, ranging from Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care and more. The company is majority owned by Fosun Pharma, one of China's leading healthcare groups. On September 19, 2017, Sisram Medical went public on the Main Board of the Hong Kong Exchange.
Sisram Medical – Enhancing Quality of Life
source: Sisram Medical Ltd
【你點睇】港鐵失倫敦伊利沙伯線專營權，你認為「國際化」遇挫的港鐵應否將重心轉移回本地？► 立即投票
